Ligand Pharmaceuticals Inc SEC filings LGNDZ

Ligand Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Ligand Pharmaceuticals Inc SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 4, 2026 —
4 Insider transaction Nov 4, 2026 Nov 2, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 3, 2026 —
4 Insider transaction Nov 3, 2026 Oct 30, 2026
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
144 Notice of proposed sale Oct 30, 2026 —
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Sep 24, 2026 Sep 22, 2026
4 Insider transaction Sep 14, 2026 Sep 10, 2026
144 Notice of proposed sale Sep 10, 2026 —
4 Insider transaction Sep 8, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
4 Insider transaction Aug 14, 2026 Aug 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2026 —
144 Notice of proposed sale Aug 12, 2026 —
144 Notice of proposed sale Aug 12, 2026 —
4 Insider transaction Aug 4, 2026 Aug 3, 2026
4 Insider transaction Jul 6, 2026 Jun 30, 2026
4 Insider transaction Jul 6, 2026 Jun 30, 2026
4 Insider transaction Jul 6, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 15, 2026 Jun 12, 2026
4 Insider transaction Jun 12, 2026 Jun 5, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
144 Notice of proposed sale Jun 12, 2026 —
144 Notice of proposed sale Jun 11, 2026 —
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Jun 10, 2026 —
144 Notice of proposed sale Jun 10, 2026 —
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 2, 2026 Jun 1, 2026
4 Insider transaction May 28, 2026 May 27, 2026
4 Insider transaction May 14, 2026 May 1, 2026
144 Notice of proposed sale May 13, 2026 —
144 Notice of proposed sale May 12, 2026 —
4 Insider transaction May 4, 2026 May 1, 2026
SCHEDULE 13D Ownership over 5% (active) May 1, 2026 —
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 1, 2026 —
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
4 Insider transaction Mar 31, 2026 Mar 6, 2026
4 Insider transaction Mar 27, 2026 Mar 2, 2026
4 Insider transaction Mar 27, 2026 Mar 2, 2026
4 Insider transaction Mar 27, 2026 Mar 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
144 Notice of proposed sale Mar 23, 2026 —
4 Insider transaction Mar 13, 2026 Mar 11, 2026
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
4 Insider transaction Feb 18, 2026 Feb 14, 2026
4 Insider transaction Feb 18, 2026 Feb 14, 2026
4 Insider transaction Feb 18, 2026 Feb 14, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Dec 31, 2025
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 9, 2025 Dec 5, 2025
4 Insider transaction Dec 8, 2025 Dec 8, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 12, 2025 Nov 7, 2025
4 Insider transaction Nov 10, 2025 Nov 6, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 10, 2025 —
144 Notice of proposed sale Nov 7, 2025 —
144 Notice of proposed sale Nov 7, 2025 —
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 3, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 1, 2025 —
4 Insider transaction Sep 24, 2025 Sep 23, 2025
4 Insider transaction Sep 24, 2025 Sep 22, 2025
144 Notice of proposed sale Sep 23, 2025 —
144 Notice of proposed sale Sep 17, 2025 —
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 12, 2025 Aug 10, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
144 Notice of proposed sale Aug 1, 2025 —
4 Insider transaction Jul 11, 2025 Jul 10, 2025
144 Notice of proposed sale Jul 10, 2025 —
SCHEDULE 13D Ownership over 5% (active) Jul 3, 2025 —
4 Insider transaction Jul 3, 2025 Jul 1, 2025
3 Initial insider ownership Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
3/A Primary document Jul 2, 2025 Nov 1, 2022
4 Insider transaction Jun 24, 2025 Jun 23, 2025
144 Notice of proposed sale Jun 23, 2025 —
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
4 Insider transaction Jun 10, 2025 Jun 6, 2025
144 Notice of proposed sale Jun 10, 2025 —
4 Insider transaction Jun 2, 2025 Aug 10, 2024
4 Insider transaction Jun 2, 2025 Jan 17, 2025
144 Notice of proposed sale May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2025 —
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction May 13, 2025 May 9, 2025
4 Insider transaction Apr 16, 2025 Apr 1, 2025
144 Notice of proposed sale Mar 18, 2025 —
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
144 Notice of proposed sale Mar 4, 2025 —
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2025 —
4 Insider transaction Dec 26, 2024 Dec 23, 2024
144 Notice of proposed sale Dec 23, 2024 —
4 Insider transaction Dec 6, 2024 Dec 5, 2024
4 Insider transaction Dec 2, 2024 Nov 27, 2024
144 Notice of proposed sale Nov 27, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 1, 2024 —
4 Insider transaction Sep 25, 2024 Sep 23, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
4 Insider transaction Sep 24, 2024 Sep 20, 2024
144 Notice of proposed sale Sep 23, 2024 —
144 Notice of proposed sale Sep 23, 2024 —
144 Notice of proposed sale Sep 20, 2024 —
144 Notice of proposed sale Sep 20, 2024 —
4 Insider transaction Sep 19, 2024 Sep 17, 2024
4 Insider transaction Sep 18, 2024 Sep 16, 2024
4 Insider transaction Aug 30, 2024 Aug 28, 2024
4 Insider transaction Aug 30, 2024 Aug 28, 2024
144 Notice of proposed sale Aug 28, 2024 —
4 Insider transaction Aug 26, 2024 Aug 22, 2024
144 Notice of proposed sale Aug 22, 2024 —
4 Insider transaction Aug 13, 2024 Aug 9, 2024
4 Insider transaction Aug 9, 2024 Aug 8, 2024
144 Notice of proposed sale Aug 9, 2024 —
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jun 25, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction Jun 18, 2024 Jun 14, 2024
4 Insider transaction May 17, 2024 May 9, 2024
4 Insider transaction May 17, 2024 May 15, 2024
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 16, 2024 —
4 Insider transaction May 15, 2024 May 13, 2024
144 Notice of proposed sale May 15, 2024 —
144/A Filing May 15, 2024 —
144 Notice of proposed sale May 14, 2024 —
144 Notice of proposed sale May 13, 2024 —
4 Insider transaction May 13, 2024 May 9, 2024
144 Notice of proposed sale May 9, 2024 —
144 Notice of proposed sale May 9, 2024 —
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction Apr 26, 2024 Apr 24, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 7, 2024 Mar 5, 2024
4 Insider transaction Mar 6, 2024 Mar 5, 2024
144 Notice of proposed sale Mar 5, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LGND (Nasdaq), LGNDZ (OTC), LGNXZ (OTC), LGNYZ (OTC), LGNZZ (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
886163
Former names
LIGAND PHARMACEUTICALS (until Sep 13, 1994)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.